Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 500

1.

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial.

Mahaffey KW, Jardine MJ, Bompoint S, Cannon CP, Neal B, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Capuano G, de Zeeuw D, Greene T, Levin A, Pollock C, Sun T, Wheeler DC, Yavin Y, Zhang H, Zinman B, Rosenthal N, Brenner BM, Perkovic V; CREDENCE study investigators.

Circulation. 2019 Jul 11. doi: 10.1161/CIRCULATIONAHA.119.042007. [Epub ahead of print]

PMID:
31291786
2.

Benefits and Risks of Lowering Sodium Through Potassium-enriched Salt Substitution for Patients with Chronic Kidney Disease in China: A Modelling Study (OR25-05-19).

Marklund M, Singh G, Greer R, Cudhea F, Matsushita K, Micha R, Brady T, Zhao D, Huang L, Tian M, Cobb L, Neal B, Appel L, Mozaffarian D, Wu J.

Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz051.OR25-05-19. doi: 10.1093/cdn/nzz051.OR25-05-19. eCollection 2019 Jun.

3.

Impact of Salt Substitute and Stepwise Reduction of Salt Supply on Blood Pressure in the Elderly in Nursing Homes (DECIDE-Salt Trial): Protocol and Baseline Characteristics (P13-022-19).

Jin A, Feng X, Zhang R, Wang H, Qiao Q, Feng L, Gao P, Fang H, Neal B, Liu K, Labarthe D, Wu Y.

Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz036.P13-022-19. doi: 10.1093/cdn/nzz036.P13-022-19. eCollection 2019 Jun.

4.

The performance and potential of the Australasian Health Star Rating system: a four-year review using the RE-AIM framework.

Jones A, Thow AM, Ni Mhurchu C, Sacks G, Neal B.

Aust N Z J Public Health. 2019 May 29. doi: 10.1111/1753-6405.12908. [Epub ahead of print]

5.

Increased hip adduction during running is associated with patellofemoral pain and differs between males and females: A case-control study.

Neal BS, Barton CJ, Birn-Jeffery A, Morrissey D.

J Biomech. 2019 Jun 25;91:133-139. doi: 10.1016/j.jbiomech.2019.05.014. Epub 2019 May 21.

PMID:
31133390
6.

The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake.

Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, Cogswell ME, McLean R, Arcand J, MacGregor G, Whelton P, Jula A, L'Abbe MR, Cobb LK, Lackland DT.

J Clin Hypertens (Greenwich). 2019 Jun;21(6):700-709. doi: 10.1111/jch.13551. Epub 2019 May 14.

7.

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.

Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Collins R, Landray MJ, Gray A, Baigent C, Mihaylova B; SHARP Collaborative Group.

Kidney Int. 2019 Jul;96(1):170-179. doi: 10.1016/j.kint.2019.01.028. Epub 2019 Mar 12.

8.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.

PMID:
30990260
9.

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.

Figtree GA, Rådholm K, Barrett TD, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Matthews DR, Shaw W, Neal B.

Circulation. 2019 May 28;139(22):2591-2593. doi: 10.1161/CIRCULATIONAHA.119.040057. Epub 2019 Mar 17. No abstract available.

PMID:
30882240
10.

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.

Matthews DR, Li Q, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Desai M, Hiatt WR, Nehler M, Fabbrini E, Kavalam M, Lee M, Neal B.

Diabetologia. 2019 Jun;62(6):926-938. doi: 10.1007/s00125-019-4839-8. Epub 2019 Mar 12.

11.

Sources of Dietary Salt in North and South India Estimated from 24 Hour Dietary Recall.

Johnson C, Santos JA, Sparks E, Raj TS, Mohan S, Garg V, Rogers K, Maulik PK, Prabhakaran D, Neal B, Webster J.

Nutrients. 2019 Feb 1;11(2). pii: E318. doi: 10.3390/nu11020318.

12.

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis.

Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine MJ, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V.

Diabetes Obes Metab. 2019 May;21(5):1237-1250. doi: 10.1111/dom.13648. Epub 2019 Mar 4.

PMID:
30697905
13.

Estimating the health benefits and cost-savings of a cap on the size of single serve sugar-sweetened beverages.

Cleghorn C, Blakely T, Mhurchu CN, Wilson N, Neal B, Eyles H.

Prev Med. 2019 Mar;120:150-156. doi: 10.1016/j.ypmed.2019.01.009. Epub 2019 Jan 18.

PMID:
30660706
14.

Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".

Figtree GA, Rådholm K, Neal B.

Circulation. 2019 Jan 15;139(3):418-419. doi: 10.1161/CIRCULATIONAHA.118.038477. No abstract available.

PMID:
30640545
15.

Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial.

Jardine MJ, Li N, Ninomiya T, Feng X, Zhang J, Shi J, Zhang Y, Zhang R, Zhang J, Hao J, Perkovic V, Heerspink HL, Wu Y, Yan LL, Neal B.

J Ren Nutr. 2019 Jul;29(4):276-284. doi: 10.1053/j.jrn.2018.10.009. Epub 2018 Dec 24.

PMID:
30591358
16.

Canagliflozin and Stroke in Type 2 Diabetes Mellitus.

Zhou Z, Lindley RI, Rådholm K, Jenkins B, Watson J, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Shaw W, Oh R, Desai M, Matthews DR, Neal B.

Stroke. 2019 Feb;50(2):396-404. doi: 10.1161/STROKEAHA.118.023009.

17.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

18.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
20.

Evaluation of a call center to assess post-discharge maternal and early neonatal outcomes of facility-based childbirth in Uttar Pradesh, India.

Gass JD Jr, Semrau K, Sana F, Mankar A, Singh VP, Fisher-Bowman J, Neal BJ, Tuller DE, Kumar B, Lipsitz S, Sharma N, Kodkany B, Kumar V, Gawande A, Hirschhorn LR.

PLoS One. 2018 Nov 27;13(11):e0207987. doi: 10.1371/journal.pone.0207987. eCollection 2018.

21.

Can front-of-pack labels influence portion size judgements for unhealthy foods? - CORRIGENDUM.

Talati Z, Pettigrew S, Kelly B, Ball K, Neal B, Dixon H, Shilton T, Miller C.

Public Health Nutr. 2019 Mar;22(3):571-572. doi: 10.1017/S1368980018003099. Epub 2018 Oct 31. No abstract available.

22.

A randomized trial assessing the effects of health claims on choice of foods in the presence of front-of-pack labels.

Talati Z, Norman R, Kelly B, Dixon H, Neal B, Miller C, Pettigrew S.

Am J Clin Nutr. 2018 Dec 1;108(6):1275-1282. doi: 10.1093/ajcn/nqy248.

PMID:
30351342
23.

Spot urine samples compared with 24-h urine samples for estimating changes in urinary sodium and potassium excretion in the China Salt Substitute and Stroke Study.

Huang L, Woodward M, Stepien S, Tian M, Yin X, Hao Z, Li Z, Sun J, Yu Y, Zhou B, Zhao Y, Wu Y, Neal B.

Int J Epidemiol. 2018 Dec 1;47(6):1811-1820. doi: 10.1093/ije/dyy206.

PMID:
30307504
24.

Risk factors for patellofemoral pain: a systematic review and meta-analysis.

Neal BS, Lack SD, Lankhorst NE, Raye A, Morrissey D, van Middelkoop M.

Br J Sports Med. 2019 Mar;53(5):270-281. doi: 10.1136/bjsports-2017-098890. Epub 2018 Sep 21.

PMID:
30242107
25.

Endoscopic Resection Followed by Proton Therapy With Pencil Beam Scanning for Skull Base Tumors.

Leeman JE, Lee NY, Zhou Y, Neal B, Sine K, Tabar V, Cohen MA.

Laryngoscope. 2019 Jun;129(6):1313-1317. doi: 10.1002/lary.27512. Epub 2018 Sep 12.

PMID:
30208224
26.

Evaluation of Alignment between the Health Claims Nutrient Profiling Scoring Criterion (NPSC) and the Health Star Rating (HSR) Nutrient Profiling Models.

Dunford EK, Huang L, Peters SAE, Crino M, Neal BC, Ni Mhurchu C.

Nutrients. 2018 Aug 10;10(8). pii: E1065. doi: 10.3390/nu10081065.

27.

Percentage of ingested sodium excreted in 24-hour urine collections: A systematic review and meta-analysis.

Lucko AM, Doktorchik C, Woodward M, Cogswell M, Neal B, Rabi D, Anderson C, He FJ, MacGregor GA, L'Abbe M, Arcand J, Whelton PK, McLean R, Campbell NRC; TRUE Consortium.

J Clin Hypertens (Greenwich). 2018 Sep;20(9):1220-1229. doi: 10.1111/jch.13353. Epub 2018 Aug 12. Review. No abstract available.

28.

Iliopsoas Abscess Due to Nephrolithiasis and Pyelonephritis.

Frank D, Neal B, Jacobs A.

Clin Pract Cases Emerg Med. 2018 May 18;2(3):264-265. doi: 10.5811/cpcem.2018.4.38206. eCollection 2018 Aug. No abstract available.

29.

Stakeholders' perceptions regarding a salt reduction strategy for India: Findings from qualitative research.

Gupta P, Mohan S, Johnson C, Garg V, Thout SR, Shivashankar R, Krishnan A, Neal B, Prabhakaran D.

PLoS One. 2018 Aug 6;13(8):e0201707. doi: 10.1371/journal.pone.0201707. eCollection 2018.

30.

Uptake of Australia's Health Star Rating System.

Jones A, Shahid M, Neal B.

Nutrients. 2018 Jul 30;10(8). pii: E997. doi: 10.3390/nu10080997.

31.

Can front-of-pack labels influence portion size judgements for unhealthy foods?

Talati Z, Pettigrew S, Kelly B, Ball K, Neal B, Dixon H, Shilton T, Miller C.

Public Health Nutr. 2018 Oct;21(15):2776-2781. doi: 10.1017/S1368980018001702. Epub 2018 Jul 18. Erratum in: Public Health Nutr. 2019 Mar;22(3):571-572.

PMID:
30017011
32.

Five year trends in the serve size, energy, and sodium contents of New Zealand fast foods: 2012 to 2016.

Eyles H, Jiang Y, Blakely T, Neal B, Crowley J, Cleghorn C, Ni Mhurchu C.

Nutr J. 2018 Jul 9;17(1):65. doi: 10.1186/s12937-018-0373-7.

33.

Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials.

Selak V, Webster R, Stepien S, Bullen C, Patel A, Thom S, Arroll B, Bots ML, Brown A, Crengle S, Dorairaj P, Elley CR, Grobbee DE, Harwood M, Hillis GS, Laba TL, Neal B, Peiris D, Rafter N, Reid C, Stanton A, Tonkin A, Usherwood T, Wadham A, Rodgers A.

Heart. 2019 Jan;105(1):42-48. doi: 10.1136/heartjnl-2018-313108. Epub 2018 Jun 28.

34.

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.

Neuen BL, Ohkuma T, Neal B, Matthews DR, de Zeeuw D, Mahaffey KW, Fulcher G, Desai M, Li Q, Deng H, Rosenthal N, Jardine MJ, Bakris G, Perkovic V.

Circulation. 2018 Oct 9;138(15):1537-1550. doi: 10.1161/CIRCULATIONAHA.118.035901.

35.

Detection of dose delivery variations on TomoTherapy using on-board detector based verification.

Hui C, Chen Q, Khandelwal S, Neal B, Watkins W.

Phys Med Biol. 2018 Jul 16;63(14):14NT02. doi: 10.1088/1361-6560/aacebb.

PMID:
29938689
36.

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.

Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Erondu N, Shaw W, Barrett TD, Weidner-Wells M, Deng H, Matthews DR, Neal B.

Lancet Diabetes Endocrinol. 2018 Sep;6(9):691-704. doi: 10.1016/S2213-8587(18)30141-4. Epub 2018 Jun 21.

37.

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.

Schrieks IC, Nozza A, Stähli BE, Buse JB, Henry RR, Malmberg K, Neal B, Nicholls SJ, Rydén L, Mellbin L, Svensson A, Wedel H, Weichert A, Lincoff AM, Tardif JC, Grobbee DE, Schwartz GG.

Diabetes Care. 2018 Aug;41(8):1792-1800. doi: 10.2337/dc18-0158. Epub 2018 Jun 14.

38.

The effects & mechanisms of increasing running step rate: A feasibility study in a mixed-sex group of runners with patellofemoral pain.

Neal BS, Barton CJ, Birn-Jeffrey A, Daley M, Morrissey D.

Phys Ther Sport. 2018 Jul;32:244-251. doi: 10.1016/j.ptsp.2018.05.018. Epub 2018 May 31.

PMID:
29879639
39.

Measuring the Healthiness of the Packaged Food Supply in Australia.

Crino M, Sacks G, Dunford E, Trieu K, Webster J, Vandevijvere S, Swinburn B, Wu JY, Neal B.

Nutrients. 2018 May 31;10(6). pii: E702. doi: 10.3390/nu10060702.

40.

Impact of CKD on Household Income.

Morton RL, Schlackow I, Gray A, Emberson J, Herrington W, Staplin N, Reith C, Howard K, Landray MJ, Cass A, Baigent C, Mihaylova B; SHARP Collaborative Group.

Kidney Int Rep. 2017 Dec 23;3(3):610-618. doi: 10.1016/j.ekir.2017.12.008. eCollection 2018 May.

41.

How to manage patellofemoral pain - Understanding the multifactorial nature and treatment options.

Lack S, Neal B, De Oliveira Silva D, Barton C.

Phys Ther Sport. 2018 Jul;32:155-166. doi: 10.1016/j.ptsp.2018.04.010. Epub 2018 Apr 12.

PMID:
29793124
42.

Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.

Zhou Z, Yu J, Carcel C, Delcourt C, Shan J, Lindley RI, Neal B, Anderson CS, Hackett ML.

BMJ Open. 2018 May 14;8(5):e019672. doi: 10.1136/bmjopen-2017-019672.

43.

Effectiveness of a WHO Safe Childbirth Checklist Coaching-based intervention on the availability of Essential Birth Supplies in Uttar Pradesh, India.

Maisonneuve JJ, Semrau KEA, Maji P, Pratap Singh V, Miller KA, Solsky I, Dixit N, Sharma J, Lagoo J, Panariello N, Neal BJ, Kalita T, Kara N, Kumar V, Hirschhorn LR.

Int J Qual Health Care. 2018 Dec 1;30(10):769-777. doi: 10.1093/intqhc/mzy086.

44.
45.

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.

Stähli BE, Nozza A, Schrieks IC, Buse JB, Malmberg K, Mellbin L, Neal B, Nicholls SJ, Rydén L, Svensson A, Wedel H, Weichert A, Lincoff AM, Grobbee DE, Tardif JC, Schwartz GG.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2522-2533. doi: 10.1210/jc.2017-02772.

46.

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review.

Rådholm K, Wu JH, Wong MG, Foote C, Fulcher G, Mahaffey KW, Perkovic V, Neal B.

Diabetes Res Clin Pract. 2018 Jun;140:118-128. doi: 10.1016/j.diabres.2018.03.027. Epub 2018 Mar 28. Review.

47.

Multisource Evaluation of Surgeon Behavior Is Associated With Malpractice Claims.

Lagoo J, Berry WR, Miller K, Neal BJ, Sato L, Lillemoe KD, Doherty GM, Kasser JR, Chaikof EL, Gawande AA, Haynes AB.

Ann Surg. 2019 Jul;270(1):84-90. doi: 10.1097/SLA.0000000000002742.

PMID:
29578910
48.

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC Jr, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J; Blood Pressure Lowering Treatment Trialists’ Collaboration.

PLoS Med. 2018 Mar 20;15(3):e1002538. doi: 10.1371/journal.pmed.1002538. eCollection 2018 Mar.

49.

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus.

Rådholm K, Figtree G, Perkovic V, Solomon SD, Mahaffey KW, de Zeeuw D, Fulcher G, Barrett TD, Shaw W, Desai M, Matthews DR, Neal B.

Circulation. 2018 Jul 31;138(5):458-468. doi: 10.1161/CIRCULATIONAHA.118.034222.

50.

Salt consumption by Australian adults: a systematic review and meta-analysis.

Land MA, Neal BC, Johnson C, Nowson CA, Margerison C, Petersen KS.

Med J Aust. 2018 Feb 5;208(2):75-81.

PMID:
29385968

Supplemental Content

Loading ...
Support Center